TSHA-106 for the treatment of angelman syndrome; TSHA-114 for the treatment of fragile X syndrome; and TSHA-101 for the treatment of GM2 gangliosidosis. The company has research, collaboration ...

Fragile X syndrome, and Angelman syndrome. It also provides ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer’s disease.

A new review sheds light on the complex molecular mechanisms behind Angelman syndrome (AS), a rare neurogenetic disorder, and ...

<a href="https://www.fox21news.com/news/local/angelman-syndrome-childrens-hospital-colorado/">https://www.fox21news.com/news/local/angelman-syndrome-childrens ...

Delores Flanders and her family are hosting a fundraiser at Boutwell’s Bowling Center in Concord to raise money for the Angelman Syndrome Foundation and support Flanders’s 3-year-old ...

May 12, 2025 /PRNewswire/ -- MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today announced that the ...

Stetson was diagnosed with Angelman syndrome a couple months later, when the results of genetic blood work revealed that he had a deleted gene on the maternally derived Chromosome 15. The neurogenetic ...

The rare neurogenetic disorder affects around 500,000 people worldwide. Rising prevalence, greater awareness and diagnosis, ...